Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

New guidance for treating blood clots

  • Comment

Guidance has been issued by the National Patient Safety Agency to ensure that a patient’s weight is known and recorded before medication is given to treat blood clots.

The rapid response report from the NPSA follows more than 2,700 patient safety incidents involving low molecular weight heparins reported to the NPSA over four-and-a-half years, including one incident that led to a death, and three that resulted in serious harm.

Underdosing with the medication can lead to an increased risk of clotting, while an overdose can lead to internal and external bleeding.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs